Longevity Target 4D pharma Files for Nasdaq Listing

4D pharma today announced it registered with the SEC to list on the Nasdaq under the symbol ‘LBPS’ following its proposed merger with Longevity Acquisition. The deal is expected to close in Q1 2021, pending shareholder approval. Shareholders earlier this week voted to grant the SPAC an extension until May 2021 to close a deal. Longevity has filed a preliminary proxy on the proposed combination. Read more.

Total
0
Shares
Related Posts